A vaccine for the common and sometimes deadly RSV (respiratory syncytial virus) has been elusive, but scientists say a new discovery puts them much closer to success.
A new study from The Ohio State University provides a potential blueprint for finding the immunological sweet spot – a vaccine weak enough that it doesn’t make people sick but strong enough that it prompts an ample immune response, ensuring that the body will recognize RSV as an intruder in the future, and quickly mount a protective defense.
